In previous experiments we analyzed the mutant frequency (MF) and mutational types in various organs of loci transgenic mice which were fed a diet containing 300 p.p.m. 2-amino-3,4-dimethylimidazo[4,5-/|quirioline (MelQ), a food-borne mutagen/carcinogen. To clarify the relationships between mutational type and adduct molecular species and between adduct level and MF we analyzed adducts in the same DNA samples. The DNA adduct in the liver, heart, colon, forestomach and bone marrow was determined by the modified intensification method of 32 P-post-labeling at time points 1,4 and 12 weeks. Only a single spot corresponding to ^-(deoxyguanosin-S-y^MelQ 5-monophosphate was detected in DNA from all organs at all time points examined, with a recovery of 48%. The difference in mutation type between bone marrow and other organs detected in the previous experiment was not explained by adduct molecular species. At 4 and 12 weeks administration the adduct levels were highest in the liver and then heart, colon, forestomach and bone marrow in decreasing order, with values of 283, 8.4, 33, 13 and 0.4 molecule/10 7 nucleotides at 12 weeks. Based on our previously reported data, loci MF was highest in the colon and those in the liver, bone marrow and forestomach were 10-60% of that of the colon; no increase in MF was detected in the heart, where no DNA replication is expected except for vascular endothelial cells. There was no direct relationship between MF and adduct level. The MF may be the product of adduct level and cell proliferation rate.
Introduction
The Big Blue™ transgenic mouse, which harbors the loci gene in a A. shuttle vector, has been established to rapidly measure in vivo mutation (Kohler et al., 1991) . Genotoxic effects of chemicals that induce genetic alterations can be efficiently detected in the Big Blue™ mouse system and the potential of in vivo mutation induction is now taken into consideration when evaluating the risks of chemicals in human carcinogenesis (Gorelick and Mirsalis, 1996; Gorelick et al, 1996; Sofuni et al, 1996) .
2-Amino-3,4-dimethylimidazo[4,5-/lquinoline (MelQ) is one of the mutagenic heterocyclic amines produced by heating meat and fish (Kasai et al., 1981) . It induces cancer of the liver and forestomach in CDF1 mice (Ohgaki et al, 1986) and of the intestine, oral cavity, Zymbal gland, skin and mammary gland in F344 rats (Kato et al, 1988) . We have previously found that feeding with MelQ induces a very high level of lad mutants in the colon (1105 X1 Ct 6 , 3 8-fold over the control) of the Big Blue™ mouse, followed by the liver (142X10" 6 , 4.5-fold), bone marrow (109X10" 6 , 5.8-fold) and forestomach (97.6X10" 6 , 2.6-fold), but no increases could be detected in the heart (20.8X10" 6 ) (Suzuki et al., 1996) . One of the major causes of these differences in mutant frequency (MF) among various organs is considered to be differences in DNA adduct levels.
Detection of DNA adducts by the 32 P-post-labeling method (Randerath et al, 1985) is the other established measure of genotoxicity of chemicals and this method is often used to monitor human exposure to carcinogens (Hemminki et al, 1990; MOller et al, 1996) . However, no reports are available demonstrating that there is a quantitative correlation between MF and DNA adduct level induced by chemicals across organs. Further, although we observed a lack of increase in lacl mutants in the heart after administration of MelQ (Suzuki et al, 1996) , it is known that adduct levels are high in the heart of rats after chronic administration of other types of heterocyclic amines, such as 2-amino-l-methyl-6-phenylimidazo [4,5-b] pyridine and 2-arnino-3-methylimidazo[4,5-/|-quinoxaline (Takayama et al., 1989; Overvick et al, 1991) .
Furthermore, we have previously analyzed mutation types of MelQ in various organs of the Big Blue™ mouse. In the liver it induced mainly G->T transversions, followed by G-»A transitions, with deletion mutations being only 6% (Ushijima et al, 1994) . Mutation type in the colon was almost the same as that observed in the liver (Okonogi et al, 1997) . Interestingly, however, in the bone marrow it was quite different, with almost the same frequencies of these three types (G->T transversions, G->A transitions and deletions) of mutation (Ushijima et al, 1994) . Although it was shown that MelQ forms an adduct on DNA, A^-(deoxyguanosin-8-yl)MeIQ (dG-C8-MeIQ), in the liver (Tada et al, 1994) , the strcture(s) of the DNA adduct in other organs has not yet been studied. One of the possible mechanisms implied by this difference in mutation type is a difference in the structures of DNA adducts in different target organs.
In this study we have analyzed molecular species of DNA adducts and DNA adduct levels in various organs of the Big Blue™ mouse after feeding with MelQ with relevance to mutation spectra and MF, which were previously reported using the same DNA samples.
Materials and methods

Animals
Sixteen Big Blue™ transgenic female mice (C57BL/6N TacfUZa]) at 6 weeks of age were provided by Stratagene (La Jolla, CA). These mice were treated as described previously (Suzuki et al, 1996) . In brief, after 1 week acclimatization at 25°C with 50% humidity in an air-conditioned room of The National Cancer Center Research Institute the mice were divided into two *To whom correspondence should be addressed. Tel: +81 3 3542 2511 ext 4520; Fax: +81 3 5565 1753; Email: mnaga@nccg.jp groups and one group was fed 300 p.p m. MelQ (Nard Institute, Osaka, Japan) in basal diet (CE-2; CLEA Japan, Tokyo, Japan). Mice were sacrificed at 1, 4 and 12 weeks after treatment. The other group was fed basal diet.
DNA preparation
The source of the DNA samples used were the same as that used for lad mutant analysis (Suzuki et al., 1996) . In brief, DNA was obtained by extraction with phenol and chloroform (Rogers et al., 1995) from the liver, heart, colon, forestomach and bone marrow separately from each of three animals, except for the forestomach. The stomach was removed from eight animals and four forestomachs were pooled and then DNA was extracted from the two pools.
Mutant frequencies
The MF values which we previoulsy obtained and have reported (Suzuki et al, 1996) are cited in this report.
Analysis of DNA adduct levels by the 32 P-post-labeling method DNA adduct levels were analyzed by the 32 P-post-labeling method with the modifications of Tada et al. (1994) . In brief, the 32 P-labeled adducts obtained by the adduct intensification method of Randerath et al. (1985) were further treated bnefly with nuclease PI and then with phosphodiesterase I (PDEI) to convert adducted oligonucleotides to adducted 5'-mononucleotides. Radio intensity of the spots was determined in a Bioimaging analyzer (BAS 2000, Fuji Photo Film Co., Tokyo, Japan).
Recovery by the 32 F'-post-labeling method
[2-l4 C]MeIQ (1.63 Gbq/mmol; Chemsyn Science Laboratory, KA) was dissolved in 0.2 ml 50% dimethylsulfoxide and administered to a 7-week-old CDF1 mouse intragastrically at 30 mg/kg. The mouse was killed 24 h later and its liver removed, frozen in liquid nitrogen and stored at -80°C until DNA extraction. DNA was extracted and purified by cesium chloride equibihum centrifugation (Brunborg et al., 1988) . A sample of DNA was hydrolyzed with DNase I (0.2 mg/mg DNA, 37°C for 30 min; Lin et al., 1992) and its radioactivity was counted in a liquid scintillation counter (LS-1801; Beckman Instruments, Irvine, CA). The adduct level was determined to be 5.8 mol MeIQ/10 7 nucleotides. The same DNA sample was subjected to 32 P-post-labeling with nuclease Pl-PDEI modified intensification and the adduct level determined to be 2.8 mol MelQ adduct/10 7 nucleotides. Figure 1 shows the TLC pattern of the MelQ-DNA adduct in the liver of the mouse. A single spot, previously identified as dG-C8-MeIQ 5'-monophosphate (Tada et al., 1994) , was exclusively detected in the experimental group of Big Blue™ mice. The same single spot was observed with DNA from bone marrow (Figure lc) . heart, colon and forestomach (data not shown) at all the time points examined and no spot was detected in the liver of untreated mice under the TLC condition used. method used in this study was demonstrated to be 48% using liver DNA from mice administered [2-14 C]MeIQ as described in Materials and methods.
Results
Molecular species of the MelQ-DNA adduct in various organs
Time course changes in DNA adduct levels in various organs
The time course study revealed that DNA adduct levels in the liver and heart increased almost linearly with the increase in administration period up to 12 weeks (Figure 2a) . In contrast, adduct levels in the colon and forestomach reached plateau levels ~1 week after initiation of MelQ administration and the same levels were retained at least up to 12 weeks (Figure 2b ). Among the five organs examined adduct level was lowest in the bone marrow, where the level increased a little with the increase in exposure time, although the increase between 4 and 12 weeks was statistically not significant. Table I summarizes lacl MF obtained and reported previously (Suzuki et al., 1996) and adduct levels at 12 weeks determined by this study. These two biological markers were obtained with the same DNA samples, as described in Materials and methods. Although the MF in the liver was only 1.2 times that in the bone marrow, the adduct level in the former was 70 times that in the latter. The MF in the colon was 9.5 times that in the liver, but adduct level in the former was only -12% of that in the latter. Also, although the MF in the bone marrow and the forestomach were almost the same, the adduct level DNA adduct level and mutagenlcity of MelQ in Big Blue mouse Three animals were used. ''Eight forestomachs in two pools were used. T5ata from a previous experiment (Suzuki et al., 1996) .
Relationship between lad MF and adduct level
in the former was about one third that of the latter. It is obvious from these data that there is no correlation between MF and adduct level.
Discussion
Only a single molecular species of DNA adduct was detected in the liver, heart, colon, forestomach and bone marrow and it showed the same migration on TLC as dG-C8-MeIQ 5'-monophosphate (Tada et al., 1994) . Thus the different mutation type of the bone marrow from those of the liver and colon, with a higher frequency of one base deletions and a lower frequency of G->T transversions in the bone marrow (Ushijima et al., 1994) , could not be explained by the structure of the adduct. We further analyzed recovery of the MelQ-DNA adduct by the 32 P-post-labeling method adopted in this study, using [2-l4 C]MeIQ; recovery was determined to be 48%. As previously reported, the standard intensification method and the nuclease Pl-PDEI modified intensification method recovered almost the same amounts of MelQ-DNA adduct (Tada et al., 1994) . Although we applied the nuclease PI and 1-butanol extraction modifications (Gupta, 1985; Reddy and Randerath, 1986) to the 32 P-post-labeling method, so far we have not been able to attain higher yields than the method used in this study. Therefore, we could not exclude the possibility that differences which exist between the bone marrow and the liver and colon are due to another adduct(s) than that which was detected by the nuclease Pl-PDEI modified intensification method.
In the liver and heart, where cell proliferation is relatively slow and almost non-existent respectively, adduct levels increased linearly until 12 weeks with chronic administration of MelQ. In contrast, in the colon and forestomach, where the cell proliferation rate is high, the adduct level reached a steady state rapidly, from ~1 to 4 weeks. This indicates that cell turnover plays a critical role in determination of adduct levels. A steady state may be attained by a balance between formation of adducts and removal of adducts by repair and cell turnover.
As shown in Table I , there was no direct correlation between MF and DNA adduct level. Although there is a time lag for DNA adduct formation resulting in mutation, the order of the organs with respect to adduct level were the same at 4 and 12 weeks (Figure 2 ). Since it is expected that the cell proliferation rate in bone marrow is higher than that in forestomach, the MF may be a consequence of two factors, cell proliferation rate and adduct level. In the heart, where cells do not proliferate, except for hemangioendothelial cells, the MF did not increase on treatment with MelQ (Table I) and it is considered that the MF is a product of DNA adduct level and cell proliferation rate.
It is generally accepted that carcinogenesis is the result of accumulation of multiple mutations (Sugimura, 1992; Kinzler and Vogelstein, 1996) . This leads to the idea that MF rather than DNA adduct level, adducts also being present in nondividing cells, is quantitatively more related to carcinogenesis. Although adduct formation is necessary for most genotoxic carcinogens to initiate carcinogenesis, this alone is not sufficient. However, the point which should be clarified is whether the MF in various organs correlates well with cancer incidence or not, including whether MelQ induces colon tumors or not in female Big Blue™ mice with the C57BL/6N genetic background.
